Pharmacogenomics approach in psychiatry disorders
Authors
Abstract:
Psychiatric disorders are important health issues in the world, and their management is facing some serious challenges. Drugs that are widely used in the treatment of psychiatric disorders, including antidepressants, antipsychotics, and mood stabilizers, are often associated with many side effects and are adequately effective only in a small proportion of patients. Many factors, including genetic factors, affect the effectiveness of medications prescribed for mental health disorders. Pharmacogenetics is the study of the association between genetic variations in genes encoding carriers, receptors, and drug-metabolizing enzymes with drug response. Many genes have been identified as affecting the drugs responsible for psychiatric disorders and genetic variation can lead to variations in the efficacy and side effects of drugs. This review article summarizes some psychiatric drugs and related genes, which could have potential functional effects.
similar resources
Prevalence of psychiatry disorders in patients with mitral valve Prolapse syndrome
SUMMARY: The mitral valve prolapse syndrome (MVPS) is a common cardiac disorder, occurring in five percent of general population. An association has been claimed between MVPS and psychiatry disorders. In this study 648 patients (mean age 32.2 years, 411 female .237 male subjects) with echocardiographically confirmed MVPS were tested for psychiatry disorders, and compared with 660 control group...
full textPharmacogenomics-A New Approach to Drug Development
Effect of a drug is not always uniform throughout the human population. Drugs working well in one patient population may not work well in another population. Furthermore, some drugs may show adverse reactions with or without intended effects. Some drugs may even fail to exert any effect. Such unpredictable drug effects are due to a generalized approach iadopted for drug development. Today's dru...
full textSupervenience and Psychiatry: Are Mental Disorders Brain Disorders?
Prominent psychiatrists have moved to rebrand psychiatry as clinical neuroscience and rechristen mental disorders as brain disorders. Recent shifts in research and funding priorities have followed suit, privileging neuroscience over psychological and behavioral research. With the possible exception of identifying general paresis with advanced syphilitic brain infection, however, no theorized id...
full textPersonalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?
CNS Spectr 13:2 February 2008 115 NEW TREND IN PSYCHOPHARMACOLOGY Personalizing medicine by understanding the unique properties of each patient’s genome has the potential of predicting what drug to prescribe for that individual. This approach has already proven useful for several drugs in medicine and promises to become a strategy for selection of therapeutics in psychiatry soon. Understanding ...
full textMy Resources
Journal title
volume 24 issue 2
pages 255- 266
publication date 2022-04
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023